Ming R. Yang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Virtual screening and cellular validation of dolutegravir as a BRD9 inhibitor for attenuating pyroptosis in peritoneal mesothelial cells.
Journal: Renal failure
Published: April 07, 2026
Biosynthesis of a N-Acetylated Tricyclic Carbazole with Antithrombotic Activity.
Journal: Journal of natural products
Published: April 22, 2025
Genetic Associations Between Gastrointestinal Diseases and Chronic Kidney Disease: An Integrated Mendelian Randomization and Bioinformatics Analysis.
Journal: Iranian journal of kidney diseases
Published: March 27, 2025
Inflammation Is More Sensitive than Cell Proliferation in Response to Rapamycin Treatment in Polycystic Kidney Disease.
Journal: Kidney & blood pressure research
Published: July 04, 2023
Misdiagnosis of renal pelvic unicentric Castleman disease: a case report.
Journal: Frontiers in surgery
Published: May 20, 2023
Iterative-Acting Thioesterase from Polyketide Biosynthesis Accepts Diverse Nucleophilic Alcohols to Yield Oxazole-Containing Esters.
Journal: Journal of agricultural and food chemistry
Published: May 06, 2023
Biosynthesis of trialkyl-substituted aromatic polyketide NFAT-133 involves unusual P450 monooxygenase-mediating aromatization and a putative metallo-beta-lactamase fold hydrolase.
Journal: Synthetic and systems biotechnology
Published: April 10, 2023
In-depth exploration of the shared genetic signature and molecular mechanisms between end-stage renal disease and osteoporosis.
Journal: Frontiers in genetics
Published: February 10, 2023
Switching Prenyl Donor Specificities in Squalene Synthase-Like Aromatic Prenyltransferases from Bacterial Carbazole Alkaloid Biosynthesis.
Journal: ACS chemical biology
Published: January 06, 2023
Carbohydrates and secondary compounds of alpine tundra shrubs in relation to experimental warming.
Journal: BMC plant biology
Published: May 04, 2021
Overexpression of miRNA-22-3p attenuates osteoporosis by targeting MAPK14.
Journal: Experimental and therapeutic medicine
Published: October 21, 2020
Last Updated: 09/26/2026